Belite Bio, Inc. ADR (D01)
FSX
127.00
-3.00 (-2.31%)
Delayed Data
Oct 26, 2026, 07:00 AM
Day's Range
127.00131.00
52 wk Range
76.50169.00
Financial Statements - D01 - Belite Bio, Inc. ADR
Revenue
0
Net Income
-77.61M▼ 114.7%
EBITDA
-77.14M▼ 116.3%
Free Cash Flow
-37.16M▼ 26.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -84.20M | -39.99M | -31.66M | -12.82M | -9.79M | -5.74M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -41K | 141K | -4K | 166K | 126K | - |
| Pre Tax Income | -77.61M | -36.13M | -31.62M | -12.64M | -9.66M | -5.75M |
| Income Tax | 0 | 6K | 9K | 0 | 0 | 1K |
| Net Income | -77.61M | -36.14M | -31.63M | -12.64M | -9.66M | -5.75M |
| EPS Basic | -2.31 | -1.18 | -1.19 | -0.63 | -0.401157 | -0.23876 |
| EPS Diluted | -2.31 | -1.18 | -1.19 | -0.63 | -0.401157 | -0.23876 |
| Basic Shares Outstanding | 33.53M | 30.53M | 28.93M | 20.79M | 25.07M | 25.07M |
| Diluted Shares Outstanding | 33.53M | 30.53M | 28.93M | 20.79M | 25.07M | 25.07M |
| Ebit | -77.60M | -36.11M | -31.59M | -12.63M | -9.66M | -5.73M |
| Ebitda | -77.14M | -35.66M | -31.19M | -12.43M | -9.63M | -5.71M |
| Net Income Continuous Operations | -77.61M | -36.14M | -31.63M | -12.64M | -9.66M | -5.75M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
